{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:31:02Z","timestamp":1782930662028,"version":"3.54.5"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Natural Science Foundation","doi-asserted-by":"publisher","award":["21ZR1400400"],"award-info":[{"award-number":["21ZR1400400"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Drug combination therapy has exhibited remarkable therapeutic efficacy and has gradually become a promising clinical treatment strategy of complex diseases such as cancers. As the related databases keep expanding, computational methods based on deep learning model have become powerful tools to predict synergistic drug combinations. However, predicting effective synergistic drug combinations is still a challenge due to the high complexity of drug combinations, the lack of biological interpretability, and the large discrepancy in the response of drug combinations in vivo and in vitro biological systems.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Here, we propose DGSSynADR, a new deep learning method based on global structured features of drugs and targets for predicting synergistic anticancer drug combinations. DGSSynADR constructs a heterogeneous graph by integrating the drug\u2013drug, drug\u2013target, protein\u2013protein interactions and multi-omics data, utilizes a low-rank global attention (LRGA) model to perform global weighted aggregation of graph nodes and learn the global structured features of drugs and targets, and then feeds the embedded features into a bilinear predictor to predict the synergy scores of drug combinations in different cancer cell lines. Specifically, LRGA network brings better model generalization ability, and effectively reduces the complexity of graph computation. The bilinear predictor facilitates the dimension transformation of the features and fuses the feature representation of the two drugs to improve the prediction performance. The loss function Smooth L1 effectively avoids gradient explosion, contributing to better model convergence. To validate the performance of DGSSynADR, we compare it with seven competitive methods. The comparison results demonstrate that DGSSynADR achieves better performance. Meanwhile, the prediction of DGSSynADR is validated by previous findings in case studies. Furthermore, detailed ablation studies indicate that the one-hot coding drug feature, LRGA model and bilinear predictor play a key role in improving the prediction performance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and implementation<\/jats:title>\n                  <jats:p>DGSSynADR is implemented in Python using the Pytorch machine-learning library, and it is freely available at https:\/\/github.com\/DHUDBlab\/DGSSynADR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btad607","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T12:16:21Z","timestamp":1696680981000},"source":"Crossref","is-referenced-by-count":28,"title":["Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5931-9006","authenticated-orcid":false,"given":"Yanglan","family":"Gan","sequence":"first","affiliation":[{"name":"School of Computer Science and Technology, Donghua University , Shanghai 201600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Computer Science and Technology, Donghua University , Shanghai 201600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Computer Science and Technology, Donghua University , Shanghai 201600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairong","family":"Yan","sequence":"additional","affiliation":[{"name":"School of Computer Science and Technology, Donghua University , Shanghai 201600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobing","family":"Zou","sequence":"additional","affiliation":[{"name":"School of Computer Engineering and Science, Shanghai University , Shanghai 200444, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"2023102510310419800_btad607-B1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4274\/tmsj.galenos.2020.07.03.02","article-title":"The effect of 5-FU and ruxolitinib on mitochondrial apoptosis in glioblastoma U87 cell line","volume":"7","author":"Aksu","year":"2020","journal-title":"TMSJ"},{"key":"2023102510310419800_btad607-B2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/07357909009012070","article-title":"Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study","volume":"8","author":"Bleiberg","year":"1990","journal-title":"Cancer Invest"},{"key":"2023102510310419800_btad607-B3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"2023102510310419800_btad607-B4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-008-9540-6","article-title":"Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?","volume":"88","author":"Boiardi","year":"2008","journal-title":"J Neurooncol"},{"key":"2023102510310419800_btad607-B5","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1073\/pnas.1337088100","article-title":"Systematic discovery of multicomponent therapeutics","volume":"100","author":"Borisy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023102510310419800_btad607-B6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"2023102510310419800_btad607-B7","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1200\/JCO.2008.18.0612","article-title":"Phase I\/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177","volume":"26","author":"Brown","year":"2008","journal-title":"J Clin Oncol"},{"key":"2023102510310419800_btad607-B8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.21.02767","article-title":"Somatic genomic testing in patients with metastatic or advanced cancer: Asco provisional clinical opinion","volume":"40","author":"Chakravarty","year":"2022","journal-title":"J Clin Oncol"},{"key":"2023102510310419800_btad607-B9","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gku476","article-title":"Lincs canvas browser: interactive web app to query, browse and interrogate lincs l1000 gene expression signatures","volume":"42","author":"Duan","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2023102510310419800_btad607-B10","first-page":"1","author":"Dwivedi"},{"key":"2023102510310419800_btad607-B11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: a gradient boosting machine","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann Stat"},{"key":"2023102510310419800_btad607-B12","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The chembl database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2023102510310419800_btad607-B13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"2023102510310419800_btad607-B14","first-page":"1440","author":"Girshick","year":"2015"},{"key":"2023102510310419800_btad607-B15","doi-asserted-by":"crossref","first-page":"bbab293","DOI":"10.1093\/bib\/bbab293","article-title":"Machine learning approaches for drug combination therapies","volume":"22","author":"G\u00fcven\u00e7 Paltun","year":"2021","journal-title":"Brief Bioinform"},{"key":"2023102510310419800_btad607-B16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s12859-019-3220-8","article-title":"Modeling aspects of the language of life through transfer-learning protein sequences","volume":"20","author":"Heinzinger","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"2023102510310419800_btad607-B17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.drudis.2020.11.030","article-title":"Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy","volume":"26","author":"Kaemmerer","year":"2021","journal-title":"Drug Discov Today"},{"key":"2023102510310419800_btad607-B18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","article-title":"Predicting drug response and synergy using a deep learning model of human cancer cells","volume":"38","author":"Kuenzi","year":"2020","journal-title":"Cancer Cell"},{"key":"2023102510310419800_btad607-B19","doi-asserted-by":"crossref","first-page":"111891","DOI":"10.1016\/j.msec.2021.111891","article-title":"Nano-synergistic combination of erlotinib and quinacrine for non-small cell lung cancer (NSCLC) therapeutics\u2014evaluation in biologically relevant in-vitro models","volume":"121","author":"Kulkarni","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2023102510310419800_btad607-B20","first-page":"2334","article-title":"Matchmaker: a deep learning framework for drug synergy prediction","author":"Kuru","year":"2021","journal-title":"IEEE\/ACM Trans Comput Biol Bioinf"},{"key":"2023102510310419800_btad607-B21","first-page":"31","author":"Landrum","year":"2013"},{"key":"2023102510310419800_btad607-B22","first-page":"3744","author":"Lee","year":"2019"},{"key":"2023102510310419800_btad607-B23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.artmed.2017.05.008","article-title":"Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles","volume":"83","author":"Li","year":"2017","journal-title":"Artif Intell Med"},{"key":"2023102510310419800_btad607-B24","doi-asserted-by":"crossref","first-page":"bbab562","DOI":"10.1093\/bib\/bbab562","article-title":"An enhanced Cascade-based deep Forest model for drug combination prediction","volume":"23","author":"Lin","year":"2022","journal-title":"Brief Bioinform"},{"key":"2023102510310419800_btad607-B25","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"2023102510310419800_btad607-B26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-020-2188-x","article-title":"A reference map of the human binary protein interactome","volume":"580","author":"Luck","year":"2020","journal-title":"Nature"},{"key":"2023102510310419800_btad607-B27","doi-asserted-by":"crossref","first-page":"e1006752","DOI":"10.1371\/journal.pcbi.1006752","article-title":"Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer","volume":"15","author":"Malyutina","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"2023102510310419800_btad607-B28","author":"Pei"},{"key":"2023102510310419800_btad607-B29","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"Deepsynergy: predicting anti-cancer drug synergy with deep learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"key":"2023102510310419800_btad607-B30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00116251","article-title":"Induction of decision trees","volume":"1","author":"Quinlan","year":"1986","journal-title":"Mach Learn"},{"key":"2023102510310419800_btad607-B31","first-page":"27","article-title":"Targeting the JAK\/STAT pathway in solid tumors","volume":"6","author":"Qureshy","year":"2020","journal-title":"J Cancer Metastasis Treat"},{"key":"2023102510310419800_btad607-B32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00685163","article-title":"Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer","volume":"27","author":"Samonigg","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"2023102510310419800_btad607-B33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fchem.2019.00509","article-title":"Predicting synergism of cancer drug combinations using nci-almanac data","volume":"7","author":"Sidorov","year":"2019","journal-title":"Front Chem"},{"key":"2023102510310419800_btad607-B34","first-page":"5998","article-title":"Attention is all you need","volume":"30","author":"Vaswani","year":"2017","journal-title":"Adv Neural Inf Process Syst"},{"key":"2023102510310419800_btad607-B35","doi-asserted-by":"crossref","first-page":"bbab390","DOI":"10.1093\/bib\/bbab390","article-title":"DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations","volume":"23","author":"Wang","year":"2022","journal-title":"Brief Bioinform"},{"key":"2023102510310419800_btad607-B36","doi-asserted-by":"crossref","first-page":"bbab587","DOI":"10.1093\/bib\/bbab587","article-title":"PRODeepSyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein\u2013protein interaction network","volume":"23","author":"Wang","year":"2022","journal-title":"Brief Bioinform"},{"key":"2023102510310419800_btad607-B37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"key":"2023102510310419800_btad607-B38","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkab438","article-title":"Drugcomb update: a more comprehensive drug sensitivity data repository and analysis portal","volume":"49","author":"Zheng","year":"2021","journal-title":"Nucleic Acids Res"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btad607\/51960026\/btad607.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/39\/10\/btad607\/52516241\/btad607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/39\/10\/btad607\/52516241\/btad607.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:31:30Z","timestamp":1698229890000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/doi\/10.1093\/bioinformatics\/btad607\/7301437"}},"subtitle":[],"editor":[{"given":"Zhiyong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btad607","relation":{},"ISSN":["1367-4811"],"issn-type":[{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,10,1]]},"article-number":"btad607"}}